CISEN(SH:603367) Zheng Quan Zhi Xing·2025-07-01 16:07Core Viewpoint - The announcement details the release of pledged shares by a major shareholder, Han Yanzhen, of Chenxin Pharmaceutical Co., Ltd, indicating a reduction in pledged shares and potential implications for shareholder confidence and company liquidity [1][2]. Shareholding Information - As of the announcement date, Han Yanzhen holds 31,977,829 shares, representing 7.06% of the company's total share capital [1]. - Han Yanzhen has released 7,920,000 shares from pledge, which accounts for 1.75% of the total share capital [1]. - After the release, Han Yanzhen has a total of 13,350,000 shares still pledged, which is 2.95% of the total share capital and 41.75% of his holdings [1]. Pledge Details - The release of the pledged shares was completed on June 27, 2025 [1]. - The released shares represent 24.77% of Han Yanzhen's total holdings [1]. - There are currently no plans for subsequent pledges of the released shares, and the company will fulfill its disclosure obligations as required by relevant laws and regulations if any new pledges occur in the future [1].